{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:15:32Z","timestamp":1788930932133,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms7410","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T10:37:46Z","timestamp":1427711866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing"],"prefix":"10.1038","volume":"6","author":[{"given":"Rozanne","family":"Arulanandam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Batenchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Varette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raunak","family":"Karmacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Babawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Waite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Falls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Garson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ilkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"K\u00e6rn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vanderhyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahum","family":"Sonenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Alain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Le Boeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Simon","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"BFncomms7410_CR1","doi-asserted-by":"publisher","first-page":"e1003836","DOI":"10.1371\/journal.ppat.1003836","volume":"10","author":"C Ilkow","year":"2014","unstructured":"Ilkow, C., Swift, S. L., Bell, J. C. & Diallo, J. S. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. PLoS Pathog. 10, e1003836 (2014) .","journal-title":"PLoS Pathog."},{"key":"BFncomms7410_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell, S. J., Peng, K. W. & Bell, J. C. Oncolytic virotherapy. Nat. Biotechnol. 30, 658\u2013670 (2012) .","journal-title":"Nat. Biotechnol."},{"key":"BFncomms7410_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10358","volume":"477","author":"CJ Breitbach","year":"2011","unstructured":"Breitbach, C. J. et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477, 99\u2013102 (2011) .","journal-title":"Nature"},{"key":"BFncomms7410_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nm.3089","volume":"19","author":"J Heo","year":"2013","unstructured":"Heo, J. et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med. 19, 329\u2013336 (2013) .","journal-title":"Nat. Med."},{"key":"BFncomms7410_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/mt.2009.283","volume":"18","author":"K Ottolino-Perry","year":"2009","unstructured":"Ottolino-Perry, K., Diallo, J. S., Lichty, B. D., Bell, J. C. & Andrea McCart, J. Intelligent design: combination therapy with oncolytic viruses. Mol. Ther. 18, 251\u2013263 (2009) .","journal-title":"Mol. Ther."},{"key":"BFncomms7410_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/77558","volume":"6","author":"DF Stojdl","year":"2000","unstructured":"Stojdl, D. F. et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6, 821\u2013825 (2000) .","journal-title":"Nat. Med."},{"key":"BFncomms7410_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","volume":"4","author":"DF Stojdl","year":"2003","unstructured":"Stojdl, D. F. et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263\u2013275 (2003) .","journal-title":"Cancer Cell"},{"key":"BFncomms7410_CR8","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1128\/JVI.77.16.8843-8856.2003","volume":"77","author":"M Obuchi","year":"2003","unstructured":"Obuchi, M., Fernandez, M. & Barber, G. N. Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J. Virol. 77, 8843\u20138856 (2003) .","journal-title":"J. Virol."},{"key":"BFncomms7410_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molcel.2004.11.023","volume":"17","author":"PA Faria","year":"2005","unstructured":"Faria, P. A. et al. VSV disrupts the Rae1\/mrnp41 mRNA nuclear export pathway. Mol. Cell 17, 93\u2013102 (2005) .","journal-title":"Mol. Cell"},{"key":"BFncomms7410_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ijc.27695","volume":"132","author":"J Brun","year":"2013","unstructured":"Brun, J. et al. Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum. Int. J. Cancer. 132, 726\u2013731 (2013) .","journal-title":"Int. J. Cancer."},{"key":"BFncomms7410_CR11","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/ncomms2974","volume":"4","author":"F Le Boeuf","year":"2013","unstructured":"Le Boeuf, F. et al. Model-based rational design of an oncolytic virus with improved therapeutic potential. Nat. Commun. 4, 1974 (2013) .","journal-title":"Nat. Commun."},{"key":"BFncomms7410_CR12","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.0400567101","volume":"101","author":"HM Chang","year":"2004","unstructured":"Chang, H. M. et al. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc. Natl Acad. Sci. USA 101, 9578\u20139583 (2004) .","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms7410_CR13","doi-asserted-by":"publisher","first-page":"14981","DOI":"10.1073\/pnas.0803988105","volume":"105","author":"TL Nguyen","year":"2008","unstructured":"Nguyen, T. L. et al. Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proc. Natl Acad. Sci. USA 105, 14981\u201314986 (2008) .","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms7410_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/mt.2010.67","volume":"18","author":"JS Diallo","year":"2010","unstructured":"Diallo, J. S. et al. A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers. Mol. Ther. 18, 1123\u20131129 (2010) .","journal-title":"Mol. Ther."},{"key":"BFncomms7410_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","volume":"38","author":"RA Terkeltaub","year":"2009","unstructured":"Terkeltaub, R. A. Colchicine update: 2008. Semin. Arthritis Rheum. 38, 411\u2013419 (2009) .","journal-title":"Semin. Arthritis Rheum."},{"key":"BFncomms7410_CR16","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/mt.2010.103","volume":"18","author":"J Brun","year":"2010","unstructured":"Brun, J. et al. Identification of genetically modified Maraba virus as an oncolytic rhabdovirus. Mol. Ther. 18, 1440\u20131449 (2010) .","journal-title":"Mol. Ther."},{"key":"BFncomms7410_CR17","first-page":"1207","volume":"63","author":"LA Martello","year":"2003","unstructured":"Martello, L. A. et al. Elevated levels of microtubule destabilizing factors in a Taxol-resistant\/dependent A549. cell line with an alpha-tubulin mutation. Cancer Res. 63, 1207\u20131213 (2003) .","journal-title":"Cancer Res."},{"key":"BFncomms7410_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF03179774","volume":"56","author":"MJ Ruiz Gomez","year":"2000","unstructured":"Ruiz Gomez, M. J., Gil, L., Souviron, A. & Martinez Morillo, M. Multidrug resistance increment in a human colon carcinoma cell line by colchicine. J. Physiol. Biochem. 56, 33\u201338 (2000) .","journal-title":"J. Physiol. Biochem."},{"key":"BFncomms7410_CR19","first-page":"1389","volume":"63","author":"DC Connolly","year":"2003","unstructured":"Connolly, D. C. et al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 63, 1389\u20131397 (2003) .","journal-title":"Cancer Res."},{"key":"BFncomms7410_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1757-2215-5-39","volume":"5","author":"K Garson","year":"2012","unstructured":"Garson, K., Gamwell, L. F., Pitre, E. M. & Vanderhyden, B. C. Technical challenges and limitations of current mouse models of ovarian cancer. J. Ovarian Res. 5, 39 (2012) .","journal-title":"J. Ovarian Res."},{"key":"BFncomms7410_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2105-10-48","volume":"10","author":"E Eden","year":"2009","unstructured":"Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10, 48 (2009) .","journal-title":"BMC Bioinformatics"},{"key":"BFncomms7410_CR22","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1371\/journal.pcbi.0030039","volume":"3","author":"E Eden","year":"2007","unstructured":"Eden, E., Lipson, D., Yogev, S. & Yakhini, Z. Discovering motifs in ranked lists of DNA sequences. PLoS Comput. Biol. 3, e39 (2007) .","journal-title":"PLoS Comput. Biol."},{"key":"BFncomms7410_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009) .","journal-title":"Nat. Protoc."},{"key":"BFncomms7410_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1\u201313 (2009) .","journal-title":"Nucleic Acids Res."},{"key":"BFncomms7410_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375\u2013386 (2005) .","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms7410_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0171-2985(96)80028-3","volume":"195","author":"Z Li","year":"1996","unstructured":"Li, Z., Davis, G. S., Mohr, C., Nain, M. & Gemsa, D. Suppression of LPS-induced tumor necrosis factor-alpha gene expression by microtubule disrupting agents. Immunobiology 195, 640\u2013654 (1996) .","journal-title":"Immunobiology"},{"key":"BFncomms7410_CR27","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/2191177a0","volume":"219","author":"PE Lacy","year":"1968","unstructured":"Lacy, P. E., Howell, S. L., Young, D. A. & Fink, C. J. New hypothesis of insulin secretion. Nature 219, 1177\u20131179 (1968) .","journal-title":"Nature"},{"key":"BFncomms7410_CR28","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1016\/S0021-9258(19)43430-3","volume":"248","author":"Y Le Marchand","year":"1973","unstructured":"Le Marchand, Y. et al. A role for the microtubular system in the release of very low density lipoproteins by perfused mouse livers. J. Biol. Chem. 248, 6862\u20136870 (1973) .","journal-title":"J. Biol. Chem."},{"key":"BFncomms7410_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.58.1.27","volume":"58","author":"RB Zurier","year":"1973","unstructured":"Zurier, R. B., Hoffstein, S. & Weissmann, G. Mechanisms of lysosomal enzyme release from human leukocytes. I. Effect of cyclic nucleotides and colchicine. J. Cell Biol. 58, 27\u201341 (1973) .","journal-title":"J. Cell Biol."},{"key":"BFncomms7410_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1083\/jcb.54.1.157","volume":"54","author":"JA Williams","year":"1972","unstructured":"Williams, J. A. & Wolff, J. Colchicine-binding protein and the secretion of thyroid hormone. J. Cell Biol. 54, 157\u2013165 (1972) .","journal-title":"J. Cell Biol."},{"key":"BFncomms7410_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature06730","volume":"452","author":"R Colina","year":"2008","unstructured":"Colina, R. et al. Translational control of the innate immune response through IRF-7. Nature 452, 323\u2013328 (2008) .","journal-title":"Nature"},{"key":"BFncomms7410_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253\u2013265 (2004) .","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms7410_CR33","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1158\/1078-0432.CCR-12-3199","volume":"19","author":"DP Conrad","year":"2013","unstructured":"Conrad, D. P. et al. Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia. Clin. Cancer Res. 19, 3832\u20133843 (2013) .","journal-title":"Clin. Cancer Res."},{"key":"BFncomms7410_CR34","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1128\/JVI.00211-06","volume":"80","author":"SC Das","year":"2006","unstructured":"Das, S. C., Nayak, D., Zhou, Y. & Pattnaik, A. K. Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J. Virol. 80, 6368\u20136377 (2006) .","journal-title":"J. Virol."},{"key":"BFncomms7410_CR35","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","volume":"83","author":"GL Smith","year":"2002","unstructured":"Smith, G. L., Vanderplasschen, A. & Law, M. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83, 2915\u20132931 (2002) .","journal-title":"J. Gen. Virol."},{"key":"BFncomms7410_CR36","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1099\/vir.0.81260-0","volume":"86","author":"E Herrero-Martinez","year":"2005","unstructured":"Herrero-Martinez, E., Roberts, K. L., Hollinshead, M. & Smith, G. L. Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J. Gen. Virol. 86, 2961\u20132968 (2005) .","journal-title":"J. Gen. Virol."},{"key":"BFncomms7410_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/cgt.2012.75","volume":"20","author":"BJ Passer","year":"2013","unstructured":"Passer, B. J. et al. Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models. Cancer Gene. Ther. 20, 17\u201324 (2013) .","journal-title":"Cancer Gene. Ther."},{"key":"BFncomms7410_CR38","doi-asserted-by":"publisher","first-page":"20047","DOI":"10.1074\/jbc.R700004200","volume":"282","author":"S Pestka","year":"2007","unstructured":"Pestka, S. The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 282, 20047\u201320051 (2007) .","journal-title":"J. Biol. Chem."},{"key":"BFncomms7410_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/01.RES.83.5.481","volume":"83","author":"B Zhou","year":"1998","unstructured":"Zhou, B. & Rabinovitch, M. Microtubule involvement in translational regulation of fibronectin expression by light chain 3 of microtubule-associated protein 1 in vascular smooth muscle cells. Circ. Res. 83, 481\u2013489 (1998) .","journal-title":"Circ. Res."},{"key":"BFncomms7410_CR40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/jcs.49.1.195","volume":"49","author":"JC Havercroft","year":"1981","unstructured":"Havercroft, J. C., Quinlan, R. A. & Gull, K. Binding of parbendazole to tubulin and its influence on microtubules in tissue-culture cells as revealed by immunofluorescence microscopy. J. Cell Sci. 49, 195\u2013204 (1981) .","journal-title":"J. Cell Sci."},{"key":"BFncomms7410_CR41","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"S Verma","year":"2012","unstructured":"Verma, S. et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. New Engl. J. Med. 367, 1783\u20131791 (2012) .","journal-title":"New Engl. J. Med."},{"key":"BFncomms7410_CR42","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/mt.2012.128","volume":"20","author":"CG Lemay","year":"2012","unstructured":"Lemay, C. G. et al. Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine. Mol. Ther. 20, 1791\u20131799 (2012) .","journal-title":"Mol. Ther."},{"key":"BFncomms7410_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-61779-340-0_10","volume":"797","author":"JS Diallo","year":"2012","unstructured":"Diallo, J. S., Vaha-Koskela, M., Le Boeuf, F. & Bell, J. Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains. Methods Mol. Biol. 797, 127\u2013140 (2012) .","journal-title":"Methods Mol. Biol."},{"key":"BFncomms7410_CR44","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/mt.2010.44","volume":"18","author":"F Le Boeuf","year":"2010","unstructured":"Le Boeuf, F. et al. Synergistic interaction between oncolytic viruses augments tumor killing. Mol. Ther. 18, 888\u2013895 (2010) .","journal-title":"Mol. Ther."},{"key":"BFncomms7410_CR45","doi-asserted-by":"publisher","first-page":"W755","DOI":"10.1093\/nar\/gkq405","volume":"38","author":"D Emig","year":"2010","unstructured":"Emig, D. et al. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 38, W755\u2013W762 (2010) .","journal-title":"Nucleic Acids Res."},{"key":"BFncomms7410_CR46","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1038\/sj.onc.1207378","volume":"23","author":"A Vultur","year":"2004","unstructured":"Vultur, A. et al. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 23, 2600\u20132616 (2004) .","journal-title":"Oncogene"},{"key":"BFncomms7410_CR47","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001) .","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms7410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms7410","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms7410.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:00:28Z","timestamp":1672920028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms7410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,5]]}},"alternative-id":["BFncomms7410"],"URL":"https:\/\/doi.org\/10.1038\/ncomms7410","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]},"assertion":[{"value":"26 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6410"}}